Clinical trials
Dermatitis clinical trials
Below are recruiting dermatitis clinical trials, each written for real people, not researchers. We’re tracking 227 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07180511Enrolling by invitationPhase 3
A study of QY201 tablets for moderate to severe eczema
This trial tests a new pill called QY201 for people with moderate to severe atopic dermatitis (eczema) that hasn't responded well to creams. It aims to see if QY201 can help control itching and skin inflammation.
Hangzhou, ZhejiangAges 18–75 - NCT06958003Enrolling by invitation
Preventing and treating diaper rash in the NICU with air time
This study is testing whether giving babies in the NICU time without a diaper (air time) helps prevent or treat diaper rash. It is for babies who are at least 30 weeks old at birth, up to 1 year old, and in stable condition.
Cincinnati, OhioAges 7 months–1 year - NCT06957444Enrolling by invitation
Allergic skin reactions and scar appearance after joint replacement
This study looks at how often patients have an allergic skin reaction to the stitches used after knee or hip replacement, and how their scar looks. If you are having a first-time replacement, you may be able to join.
Morgantown, West VirginiaAges 18–80 - NCT06947252Enrolling by invitation
Food allergy test for kids with eczema avoiding certain foods
This trial tests if children with eczema who avoid certain foods actually have a food allergy. It uses a supervised oral food challenge to confirm.
BangkokAges Up to 6 years - NCT06464133Enrolling by invitation
Filaggrin gene study in Latinx patients with eczema
This study looks for gene changes (filaggrin mutations) in Latinx/Hispanic patients with atopic dermatitis (eczema) to better understand how these genes affect the condition. It involves a simple skin test or saliva sample.
Philadelphia, PennsylvaniaAges Any age - NCT06178289Enrolling by invitation
Skin protectant for moisture damage in hospitals
This trial tests a new skin protectant lotion for people in the hospital with skin damage from moisture (like urine or stool). It aims to see if the lotion helps heal these wounds better than current care.
AntwerpAges 18 years+ - NCT06158490Enrolling by invitationPhase 2
JYP0061 tablet for moderate to severe eczema
This trial tests a new tablet called JYP0061 for people with moderate to severe atopic dermatitis (eczema) that has lasted at least a year. It aims to see if the drug is safe and effective in reducing symptoms.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT05735483Enrolling by invitationPhase 3
Long-term lebrikizumab study for moderate to severe eczema
This Phase 3 trial studies whether lebrikizumab is safe and continues to work over the long term for children and teens with moderate-to-severe atopic dermatitis (eczema). It’s meant for people who already finished a related earlier study and can safely continue.
Birmingham, AlabamaAges 6 months–18 years - NCT04504955Enrolling by invitation
Atopic dermatitis patient registry for medication safety and results
This study is a real-world registry that collects information from adults with atopic dermatitis (eczema) to track how newly started treatments work and how safe they are over time. It may help researchers and doctors better understand medication effects in everyday care.
Waltham, MassachusettsAges 18 years+ - NCT03976622Enrolling by invitation
Inflammation study in vitiligo and other skin conditions
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
Bordeaux, BordeauxAges 18–75 - NCT05316805Recruiting
Study for type 2 inflammatory skin rashes and hives
This study looks at people with certain types of inflammatory skin conditions to improve how they are diagnosed and treated. It may help your care team by using a standardized approach, but you must be able to complete questionnaires and consent to participate.
BeijingAges Any age - NCT07693738RecruitingPhase 1
SSGJ-716 for healthy adults and people with atopic dermatitis
This trial tests a new medicine, SSGJ-716, in healthy adults and in people with moderate-to-severe atopic dermatitis (a type of eczema). It aims to see if the drug is safe and how the body reacts to it.
ShanghaiAges 18–45 - NCT07559877RecruitingPhase 3
Chlorhexidine spray to prevent radiation skin damage in throat cancer
This study tests whether a chlorhexidine spray (an antiseptic liquid) can prevent or reduce skin damage caused by radiation therapy in people being treated for nasopharyngeal cancer (cancer in the back of the nose/throat). Radiation dermatitis—painful redness and irritation of the skin—is a common side effect, and this spray may help protect your skin during treatment.
Nanchang, JiangxiAges 18–75 - NCT06923202Recruiting
Studying alloknesia in atopic dermatitis
This study looks at a condition called alloknesia (a feeling that a light touch is painful) in people with atopic dermatitis (a type of eczema). It aims to understand how common this is and what it feels like.
AngersAges 18 years+ - NCT06499896RecruitingPhase 2
Donor microbiome pills for steroid-resistant skin or colon side effects
This trial tests whether a pill made from healthy donor bacteria (MTP-101-C) can help patients whose immune-related skin rash or colon inflammation did not improve with steroids. It's for people who had these side effects after receiving immunotherapy for cancer.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07748169Recruiting
Observational study of skin disease patients
This study looks at the health records of people with skin diseases to learn more about their care and outcomes. It may help improve future treatments.
Winston-Salem, North CarolinaAges Any age - NCT07228962Recruiting
Skin clues for eczema in babies
This study looks at tiny skin samples from babies to find clues about eczema. It uses a gentle, painless device that sucks up a small piece of skin. If your baby has eczema or is healthy and under 6 months old, you may be able to join.
LondonAges birth–6 months - NCT06994520Enrolling by invitationPhase 2
Topical cannabis extract for eczema itch
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
Khon Kaen, Changwat Khon KaenAges 25 years+ - NCT06943469Recruiting
Study of special formula for babies with allergy risk
This study tests a special baby formula (partially broken-down protein with added prebiotics and probiotics) to see if it helps strengthen babies' skin barrier and reduce allergy risk. It's designed for newborns who have a family history of allergies.
BrugesAges 1 day–2 weeks - NCT07216027RecruitingPhase 2
A study of a new eczema medicine for adults
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
Huntington Beach, CaliforniaAges 18–64 - NCT07729423Recruiting
Mepitel Film for skin protection during breast radiation
This trial tests if a special film placed on the skin can reduce radiation side effects in people who have had breast cancer surgery and are now getting radiation therapy.
SingaporeAges 21–100 - NCT06807281RecruitingPhase 3
Abrocitinib for children with eczema: long-term study
This study tests the long-term safety and effectiveness of abrocitinib (Cibinqo) for children aged 6 to 12 with moderate to severe eczema that hasn't improved with creams. It may help their skin clear and reduce itching.
Birmingham, AlabamaAges 2–11 - NCT06564389RecruitingPhase 1
First-in-human study of PF-07832837 in healthy adults and eczema patients
This trial is testing a new investigational medicine (PF-07832837) for safety in healthy adults and in people with moderate to severe atopic dermatitis (eczema). It is a first-in-human study, so it looks at how well the body tolerates the medicine.
Anaheim, CaliforniaAges 18–70 - NCT07676253Recruiting
Helichrysum cream for skin irritation in healthy volunteers
This trial tests a cream made from an herb called Helichrysum italicum (sometimes called 'curry plant') to see if it can help soothe skin irritation caused by contact with irritants. Researchers want to see if it reduces redness and discomfort in healthy volunteers.
SplitAges 18–50
Hear when a new Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for dermatitis?
- Yes. Clin2 currently lists 227 recruiting dermatitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dermatitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dermatitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.